Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36, N.5, and our video podcast, CANCER BUZZ TV.

National Policy Resources—Local Advocacy Results

As cancer care professionals who experience the challenges of providing quality cancer care first-hand, IOS members are well positioned to educate decision-makers on how coverage and reimbursement issues affect community oncology. State and federal legislation can have a significant impact on the financial viability of local cancer programs, which is why it's so important that our members make their voices heard.

In an effort to provide resources needed to effectively advocate on the issues that are important to them, our redesigned advocacy webpage features activity from the Centers for Medicare & Medicaid Services (CMS), national healthcare coverage through the Association of Community Cancer Centers (ACCC), local news articles and webinars, and more.

We want to hear from you! If there is a specific piece of legislation you want to know more about, an important resource we're missing, or if you want to get more involved, please contact us!

Federal Advocacy

IOS Joins Coalition Letter Urging Addition of the Cures 2.0 Concept Paper Title IV Provisions in the Next COVID-19 Relief Package

The Iowa  Oncology Society (IOS) joined in a coalition letter to congressional leadership urging that Congress include the 21st Century Cures 2.0 concept paper, recently released by Representatives Diana DeGette and Fred Upton in upcoming legislation to further address the COVID-19 public health crisis. Specifically the letter urges leadership to include policy to provide Medicaid coverage of the routine care costs of clinical trials participation for patients with life-threatening conditions in every state. This critical protection is championed by Representatives Ben Ray Luján and Gus Bilirakis in the Clinical Treatment Act (H.R. 913).

 

ACCCBuzz Blog Posts

  • Health Policy
    National Paid Family and Medical Leave May be on the Horizon
    September 24, 2021
    Despite the havoc it has caused, our continuously unfolding public health emergency has given us hope that some elusive policy initiatives are now not the stretch they once were.
  • Prostate Cancer Awareness Ribbon
    ACCC Recognizes Prostate Cancer Awareness Month
    September 14, 2021
    ACCC has long highlighted the racial and ethnic disparities that exist in oncology and hematology care delivery to advocate for true health equity for all patients with cancer. Through various programs, ACCC helps teach members of the multidisciplinary cancer care team how they can help patients overcome barriers and disparities in various treatment settings.
  • Despite Setbacks, Biosimilars Market Share Continues to Increase
    By Blake McCreery-Cullifer, CPRP
    September 10, 2021
    With total spending on U.S. cancer care projected to rise 34 percent from 2015-2030 to $245 billion, biosimilars can play a role in helping reduce those costs. Learn how Biden’s executive order on promoting competition in the American economy will require the FDA's biosimilars approval framework to be clearer and easier to follow.

1801 Research Boulevard Suite 400
Rockville, MD 20850
Tel: 301.984.9496 | Fax: 301.770.1949
ios-iowa.com
Email Us